January 30 is a busy earnings day for Indian markets, with a large number of companies across sectors announcing their Q3 financial results for the quarter ended December 2025. From heavyweight PSU players and blue-chip FMCG names to pharma, cement, banking, power, and mid-cap industrial firms, today’s earnings calendar is packed and could drive stock-specific action through the session.
Several marquee names are in focus, including Nestle India Ltd., NTPC Ltd., Power Grid Corporation of India Ltd., Bank of Baroda, Bajaj Auto Ltd., Ambuja Cements Ltd., LIC Housing Finance Ltd., Dr. Lal PathLabs Ltd., and National Aluminium Company Ltd..
The banking and financial services space is particularly active, with results due from lenders and NBFCs such as Cholamandalam Investment and Finance Company Ltd., ESAF Small Finance Bank Ltd., Northern Arc Capital Ltd., Tourism Finance Corporation of India Ltd., and Manraj Housing Finance Ltd.
In the FMCG, consumption, and lifestyle segment, earnings from Procter & Gamble Hygiene and Health Care Ltd., Godfrey Phillips India Ltd., Relaxo Footwears Ltd., Navneet Education Ltd., and Medplus Health Services Ltd. are expected to reflect demand trends during the festive and early winter period.
The pharma and healthcare space is also in focus, with results scheduled from Ajanta Pharma Ltd., Glenmark Pharmaceuticals Ltd., Strides Pharma Science Ltd., Aster DM Healthcare Ltd., and Jupiter Life Line Hospitals Ltd..
From the infrastructure, power, and metals pack, market participants will track earnings from Steel Authority of India Ltd., Jindal Steel Ltd., Welspun Corp Ltd., KEC International Ltd., Ashoka Buildcon Ltd., and Reliance Power Ltd.. Performance in these names may set the tone for sectoral sentiment.
Apart from large and mid-cap stocks, a long list of small-cap and micro-cap companies across textiles, chemicals, packaging, logistics, education, and specialty manufacturing are also declaring their Q3 numbers today.
Disclaimer: This article is for informational purposes only. It is not intended to be investment advice or a recommendation to buy or sell any stock. Readers are advised to consult their financial advisor before making any investment decisions.
